Lisa K Sadzewicz

Title: Lisa K Sadzewicz: Innovator in Cancer Genetics

Introduction

Lisa K Sadzewicz is a prominent inventor based in Laurel, MD (US). She has made significant contributions to the field of cancer genetics, particularly through her research on the BRCA1 gene. With a total of 2 patents, her work has the potential to impact the diagnosis and treatment of breast and ovarian cancer.

Latest Patents

Sadzewicz's latest patents focus on critical mutations in the BRCA1 gene. One patent details the discovery of new mutations located at nucleotide numbers 421-2, 815, 903, 926, 1506, 2034, 2428, 3888, 3904, 4164, 4643, 5053, 5150, 5210, or 5396+40 of the BRCA1 gene sequence. This invention provides a process for identifying sequence variations in BRCA1 polynucleotide sequences, utilizing allele-specific sequence-based assays for accurate mutation detection. Another patent addresses a two base pair deletion at nucleotides 3888 and 3889 of the published cDNA sequence of BRCA1. This invention offers a method for diagnosing individuals at risk of developing breast or ovarian cancer and serves as a tool for tumor characterization.

Career Highlights

Lisa K Sadzewicz is associated with Oncormed, Inc., where she continues her groundbreaking work in cancer research. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in genetic testing and cancer susceptibility.

Collaborations

Sadzewicz collaborates with notable colleagues, including Marga Belle White and Sheri J Olson. Their combined expertise enhances the research efforts at Oncormed, Inc., fostering an environment of innovation and discovery.

Conclusion

Lisa K Sadzewicz stands out as a key figure in the field of cancer genetics, with her patents paving the way for improved diagnostic methods. Her contributions are vital in the ongoing fight against breast and ovarian cancer.